RGC logo

RGC

Profile

Full Name

Regencell Bioscience Holdings Limited

Ticker Symbol

RGC

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Hong Kong

IPO

July 16, 2021

Indexes

Not included

Website

http://www.regencellbioscience.com

Employees

12

Key Details

Price

$32.21(+32.55%)

Market cap

$440.10M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.33(+26.67% YoY)

PE ratio

-

Next earnings date

Jun 20, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$32.21
RGC price is $32.21

30-Day Relative Volume

0.18
RGC 30-day relative volume is 0.18

Price Range

Price All-time high

$58.63
RGC price is currently -45.06% below its historical high of $58.63

Price 3-year low

$3.20
RGC price is currently +905.31% above its 3-year low

Price Performance

Price Most recent change

+32.55%
RGC price was up +32.55% on Apr 4, 2025

Price YTD change

+552.02%
RGC price is up +552.02% since January 1st

Price 1-year change

+765.86%
RGC price is up +765.86% year-on-year

Price 3-year change

+37.47%
RGC price is up +37.47% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$440.10M
RGC market capitalization is $440.10 million

Market cap 3-year change

+44.34%
RGC market capitalization is up +44.34% over the past 3 years

Market cap All-time high

$839.33M
RGC market capitalization is currently -47.57% below its historical high of $839.33 million

Market cap sector rank

68.47%
RGC market capitalization is higher than 68.47% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
RGC {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

0%
RGC {parameterFullLabel} has remained unchanged over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-2.19
RGC beta is -2.19

200-day SMA

$7.91
RGC price is currently +307.02% above its 200-day simple moving average

50-day SMA

$13.41
RGC price is currently +140.27% above its 50-day simple moving average

RSI

56.86
RGC 14-day relative strength index is 56.86

Volume

0.18
RGC 30-day relative volume is 0.18

ATR

$9.85
RGC average true range is $9.85

10-day Historical Volatility

323.08%
RGC 10-day historical volatility is 323.08%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
RGC annual revenue value is unknown

Revenue Analysts estimate

-
RGC annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
RGC annual revenue 1-year change is unknown

Revenue Sector rank

-
RGC annual revenue is unknown

EPS

EPS

-$0.33
RGC annual earnings per share is -$0.33

EPS Analysts estimate

-
RGC annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+26.67%
RGC annual earnings per share is up +26.67% year-on-year

EPS Sector rank

72.07%
RGC annual earnings per share is higher than 72.07% of companies in Healthcare sector

Profit

Gross profit

-
RGC annual gross profit value is unknown

Gross margin

-
RGC annual gross profit margin value is unknown

Operating profit

-$4.74M
RGC annual operating income is -$4.74 million

Operating margin

-
RGC annual operating profit margin value is unknown

Net income

-$4.30M
RGC annual net profit is -$4.30 million

Net margin

-
RGC annual net profit margin value is unknown

Expenses

Total expenses

$4.74M
RGC annual total expenses is $4.74 million

Operating expenses

$4.74M
RGC annual total operating expenses is $4.74 million

Cost of goods sold

-
RGC annual cost of goods sold value is unknown

Selling, general & administrative expenses

$3.67M
RGC annual SGA is $3.67 million

Depreciation and amortization

$745.60K
RGC annual depreciation & amortization is $745.60 thousand

Interest expense

-
RGC annual interest expense value is unknown

Income tax

$0.00
RGC annual income tax is $0.00

EBIT & EBITDA

EBIT

-$4.74M
RGC annual earnings before interest & taxes is -$4.74 million

EBITDA

-$3.99M
RGC annual EBITDA is -$3.99 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$8.44M
RGC annual total assets is $8.44 million

Non current assets

$324.20K
RGC annual long term assets is $324.20 thousand

Current assets

$8.11M
RGC annual total current assets is $8.11 million

Cash and cash equivalents

$2.96M
RGC annual cash & cash equivalents is $2.96 million

Accounts receivable

-
RGC annual accounts receivable value is unknown

Inventory

-
RGC annual inventory value is unknown

Liabilities

Total liabilities

$219.50K
RGC annual total liabilities is $219.50 thousand

Long term liabilities

$25.90K
RGC annual total long term liabilities is $25.90 thousand

Current liabilities

$193.60K
RGC annual total current liabilities is $193.60 thousand

Accounts payable

-
RGC annual accounts payable value is unknown

Debt

Total debt

$85.70K
RGC annual total debt is $85.70 thousand

Total debt 1-year change

-81.52%
RGC annual total debt is down -81.52% year-on-year

Long term debt

$25.90K
RGC annual long term debt is $25.90 thousand

Short term debt

$59.80K
RGC annual short term debt is $59.80 thousand

Equity & Capital

Shareholders equity

$8.22M
RGC annual stockholders equity is $8.22 million

Book value

$8.22M
RGC annual book value is $8.22 million

Retained earnings

-$21.62M
RGC annual retained earnings is -$21.62 million

Working capital

$7.92M
RGC annual working capital is $7.92 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$4.00M
RGC annual cash flow from operations is -$4.00 million

Cash from operations 1-year change

+19.37%
RGC annual cash flow from operations is up +19.37% year-on-year

Cash from investing

$5.24M
RGC annual cash flow from investing activities is $5.24 million

Cash from investing 1-year change

+8785.76%
RGC annual cash flow from investing activities is up +8785.76% year-on-year

Cash from financing

$102.30K
RGC annual cash flow from financing activities is $102.30 thousand

Cash from financing 1-year change

-24.17%
RGC annual cash flow from financing activities is down -24.17% year-on-year

CAPEX

CAPEX

-
RGC annual capital expenditures value is unknown

CAPEX 1-year change

-
RGC annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$4.01M
RGC annual free cash flow is -$4.01 million

Free cash flow 1-year change

+19.7%
RGC annual free cash flow is up +19.7% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
RGC annual gross profit margin value is unknown

Operating margin

-
RGC annual operating profit margin value is unknown

Net margin

-
RGC annual net profit margin value is unknown

ROA & ROE

ROA

-50.98%
RGC annual return on assets is -50.98%

ROE

-52.34%
RGC annual return on equity is -52.34%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
RGC price to earnings ratio value is unknown

PE ratio Sector rank

-
RGC price to earnings ratio is unknown

PB Ratio

PB ratio

53.55
RGC price to book ratio is 53.55

PB ratio Sector rank

98.85%
RGC price to book ratio is higher than 98.85% of companies in Healthcare sector

PS Ratio

PS ratio

-
RGC price to sales ratio value is unknown

PS ratio Sector rank

-
RGC price to sales ratio is unknown

Enterprise value

Enterprise value

$437.22M
RGC enterprise value is $437.22 million

Enterprise value Sector rank

68.46%
RGC enterprise value is higher than 68.46% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
RGC EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
RGC EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

41.91
RGC annual current ratio is 41.91

Quick ratio

-
RGC annual quick ratio value is unknown

Leverage

Debt to equity

0.01
RGC annual debt to equity ratio is 0.01

Interest coverage ratio

-
RGC annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
RGC piotroski f-score value is unknown

Altman Z-Score

-
RGC altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

Sionna Therapeutics (SION)
TALK logo
Talkspace (TALK)
PRTC logo
PureTech Health (PRTC)
MGTX logo
MeiraGTx Holdings (MGTX)
MDRX logo
Veradigm (MDRX)
CGEM logo
Cullinan Oncology (CGEM)
OnKure Therapeutics (OKUR)
CTKB logo
Cytek Biosciences (CTKB)
AKBA logo
Akebia Therapeutics (AKBA)
  • What is the ticker symbol for Regencell Bioscience Holdings Limited?
  • Does Regencell Bioscience Holdings Limited pay dividends?
  • What sector is Regencell Bioscience Holdings Limited in?
  • What industry is Regencell Bioscience Holdings Limited in?
  • What country is Regencell Bioscience Holdings Limited based in?
  • When did Regencell Bioscience Holdings Limited go public?
  • Is Regencell Bioscience Holdings Limited in the S&P 500?
  • Is Regencell Bioscience Holdings Limited in the NASDAQ 100?
  • Is Regencell Bioscience Holdings Limited in the Dow Jones?
  • When was Regencell Bioscience Holdings Limited's last earnings report?
  • When does Regencell Bioscience Holdings Limited report earnings?

What is the ticker symbol for Regencell Bioscience Holdings Limited?

The ticker symbol for Regencell Bioscience Holdings Limited is NASDAQ:RGC

Does Regencell Bioscience Holdings Limited pay dividends?

No, Regencell Bioscience Holdings Limited does not pay dividends

What sector is Regencell Bioscience Holdings Limited in?

Regencell Bioscience Holdings Limited is in the Healthcare sector

What industry is Regencell Bioscience Holdings Limited in?

Regencell Bioscience Holdings Limited is in the Drug Manufacturers - Specialty & Generic industry

What country is Regencell Bioscience Holdings Limited based in?

Regencell Bioscience Holdings Limited is headquartered in Hong Kong

When did Regencell Bioscience Holdings Limited go public?

Regencell Bioscience Holdings Limited's initial public offering (IPO) was on July 16, 2021

Is Regencell Bioscience Holdings Limited in the S&P 500?

No, Regencell Bioscience Holdings Limited is not included in the S&P 500 index

Is Regencell Bioscience Holdings Limited in the NASDAQ 100?

No, Regencell Bioscience Holdings Limited is not included in the NASDAQ 100 index

Is Regencell Bioscience Holdings Limited in the Dow Jones?

No, Regencell Bioscience Holdings Limited is not included in the Dow Jones index

When was Regencell Bioscience Holdings Limited's last earnings report?

Regencell Bioscience Holdings Limited's most recent earnings report was on Jun 20, 2024

When does Regencell Bioscience Holdings Limited report earnings?

The next expected earnings date for Regencell Bioscience Holdings Limited is Jun 20, 2025
On this page